Eligard is a luteinizing hormone-releasing hormone (LHRH) agonist. Tolmar announced that the Food and Drug Administration (FDA) has approved a label update for Eligard (leuprolide acetate for ...
The active ingredient of Eligard® is leuprorelin acetate, a powder which is solubilized with a solvent for subcutaneous injection. Eligard® is available in three different dosages (for 1-month, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results